Featured Research

from universities, journals, and other organizations

End-of-life Preferences Appear To Remain Stable As Health Declines

Date:
October 27, 2008
Source:
JAMA and Archives Journals
Summary:
Most individuals' preferences regarding life-sustaining treatment do not appear to change over a three-year period, regardless of declines in physical and mental health, according to a new report. Individuals who say they want aggressive care and those without advance directives are most likely to change their end-of-life wishes over time.

Most individuals' preferences regarding life-sustaining treatment do not appear to change over a three-year period, regardless of declines in physical and mental health, according to a new report. Individuals who say they want aggressive care and those without advance directives are most likely to change their end-of-life wishes over time.

"Efforts to improve the experience of patients and families at the end of life must incorporate patient perspectives," the authors write as background information in the article. "Advance directives are one strategy through which patient preferences can be elicited and recorded, to be invoked at a time when the patient may not be able to make decisions directing care." However, they note, preferences for life-sustaining treatment given in one state of health may not reflect the choices patients would make if their health status changed.

Marsha N. Wittink, M.D., M.B.E., of the University of Pennsylvania School of Medicine, Philadelphia, and colleagues assessed end-of-life preferences in 818 physicians (average age 69) who graduated from medical school at Johns Hopkins University between 1948 and 1964. Participants completed questionnaires about their health status and their end-of-life preferences in 1999 and again in 2002. They were asked to consider what treatments they would want in the event of brain death that left them unable to speak or recognize people. They reported how likely they were to desire each of 10 interventions, including cardiopulmonary resuscitation, major surgery, a feeding tube and dialysis.

The physicians were divided into three clusters based on their preferences: those who would want most of the interventions were classified as preferring aggressive care (12 percent in 1999 and 14 percent in 2002), those who would want intravenous fluids and antibiotics as the primary interventions as preferring intermediate care (26 percent in 1999 and 26 percent in 2002) and those who would decline most interventions as desiring least aggressive care (62 percent in 1999 and 60 percent in 2002).

"In general, procedures that were declined in 1999 were likely also to be declined in 2002," the authors write. "Nevertheless, a substantial proportion of persons who desired an intervention in 1999 declined the treatment in 2002." A total of 41 percent of those who said they desired aggressive care in 1999 remained in that category in 2002. In addition, physicians who did not have a living will or durable power of attorney were twice as likely to transition to the most aggressive category as those without advance directives. Age and declines in mental and physical health were not associated with transitions to either more or less aggressive care.

"We believe that the results of this study suggest that although physician-respondents were relatively stable in their preferences, persons without advance directives and who desired the most aggressive treatment at baseline exhibited the most changeable preferences," the authors write. "Persons who express a desire for aggressive treatment and those who have not communicated their wishes with a more formal written document (advance directives) may require frequent clinical re-evaluation to assess whether wishes have changed."

Dr. Wittink was supported by Mentored Patient-Oriented Research Career Development Award from the National Institute of Mental Health. The Johns Hopkins Precursors Study was supported by grants from the National Institutes of Health.


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. Marsha N. Wittink; Knashawn H. Morales; Lucy A. Meoni; Daniel E. Ford; Nae-yuh Wang; Michael J. Klag; Joseph J. Gallo. Stability of Preferences for End-of-Life Treatment After 3 Years of Follow-up: The Johns Hopkins Precursors Study. Arch Intern Med., 2008;168(19):2125-2130 [link]

Cite This Page:

JAMA and Archives Journals. "End-of-life Preferences Appear To Remain Stable As Health Declines." ScienceDaily. ScienceDaily, 27 October 2008. <www.sciencedaily.com/releases/2008/10/081027174551.htm>.
JAMA and Archives Journals. (2008, October 27). End-of-life Preferences Appear To Remain Stable As Health Declines. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/10/081027174551.htm
JAMA and Archives Journals. "End-of-life Preferences Appear To Remain Stable As Health Declines." ScienceDaily. www.sciencedaily.com/releases/2008/10/081027174551.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins